{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:45:48Z","timestamp":1791499548863,"version":"4.3.4"},"reference-count":163,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion Medicine Reviews"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.tmrv.2012.04.004","type":"journal-article","created":{"date-parts":[[2012,5,24]],"date-time":"2012-05-24T10:56:07Z","timestamp":1337856967000},"page":"281-304.e2","source":"Crossref","is-referenced-by-count":46,"title":["The National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Studies (Retrovirus Epidemiology Donor Study and Retrovirus Epidemiology Donor Study-II): Twenty Years of Research to Advance Blood Product Safety and Availability"],"prefix":"10.1016","volume":"26","author":[{"given":"Steven","family":"Kleinman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa R.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward L.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone A.","family":"Glynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmrv.2012.04.004_bb0005","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1046\/j.1537-2995.1995.351196110900.x","article-title":"The Retrovirus Epidemiology Donor Study (REDS): Rationale and methods","volume":"35","author":"Zuck","year":"1995","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0010","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJM199606273342601","article-title":"The risk of transfusion-transmitted viral infections","volume":"334","author":"Schreiber","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0015","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1053\/tmrv.1997.0110155","article-title":"The Incidence\/Window Period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection","volume":"11","author":"Kleinman","year":"1997","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0020","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1056\/NEJM199512283332601","article-title":"Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States","volume":"333","author":"Lackritz","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0025","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1046\/j.1537-2995.1997.37697335159.x","article-title":"A method for estimating Hepatitis B virus incidence rates in volunteer blood donors","volume":"37","author":"Korelitz","year":"1997","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0030","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1537-2995.2004.04215.x","article-title":"A new strategy for estimating risk of transfusion-transmitted viral infections based on rates of detection of recently infected donors","volume":"45","author":"Busch","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0035","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/jama.284.2.229","article-title":"Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996","volume":"284","author":"Glynn","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0040","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/j.1537-2995.2005.00178.x","article-title":"Does prevalence of transfusion-transmissible viral infections reflect corresponding incidence in United States blood donors?","volume":"45","author":"Wang","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0045","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1046\/j.1537-2995.2001.41060730.x","article-title":"Incidence rates of viral infections among repeat donors: Are frequent donors safer?","volume":"41","author":"Schreiber","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0050","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1046\/j.1537-2995.2000.40080954.x","article-title":"Infectious disease markers in young blood donors","volume":"40","author":"Watanabe","year":"2000","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0055","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1046\/j.1537-2995.2003.00399.x","article-title":"Prevalence of transfusion-transmissible viral infections in first-time US blood donors by donation site","volume":"43","author":"Wang","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0060","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1046\/j.1537-2995.2002.00200.x","article-title":"International application of the Incidence Rate\/Window Period model","volume":"42","author":"Glynn","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0065","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1046\/j.1537-2995.2003.00424.x","article-title":"Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection","volume":"43","author":"Biswas","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0070","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/j.1537-2995.2005.04390.x","article-title":"Dynamics of viremia in early hepatitis C virus infection","volume":"45","author":"Glynn","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0075","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1097\/00002030-200309050-00005","article-title":"Dynamics of HIV viremia and antibody seroconversion in plasma donors: Implications for diagnosis and staging of primary HIV infection","volume":"17","author":"Fiebig","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0080","first-page":"113","article-title":"Intermittent low-level viremia in very early primary HIV-1 infection","volume":"39","author":"Fiebig","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0085","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1111\/j.1537-2995.2009.02322.x","article-title":"Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion","volume":"49","author":"Kleinman","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0090","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1056\/NEJMoa040085","article-title":"Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing","volume":"351","author":"Stramer","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0095","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1111\/j.1537-2995.2005.00649.x","article-title":"Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection","volume":"45","author":"Busch","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0100","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1001\/jama.280.12.1080","article-title":"False-positive HIV-1 test results in a low-risk screening setting of voluntary blood donation","volume":"280","author":"Kleinman","year":"1998","journal-title":"JAMA"},{"issue":"Suppl.","key":"10.1016\/j.tmrv.2012.04.004_bb0105","first-page":"98S","article-title":"HIV p24 antigen indeterminate donors are not infected with HIV","volume":"37","author":"Kleinman","year":"1997","journal-title":"Transfusion"},{"issue":"Suppl.","key":"10.1016\/j.tmrv.2012.04.004_bb0110","first-page":"109S","article-title":"Use of a PCR-amplified reverse transcriptase assay (amp-RT) to rule out occult retrovirus infection in donors with positive HIV p24 antigen neutralization results","volume":"37","author":"Busch","year":"1997","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0115","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1537-2995.1996.36196190513.x","article-title":"Frequency of human immunodeficiency virus (HIV) infection among contemporary anti-HIV-1 and anti-HIV-1\/2 supplemental test-indeterminate blood donors","volume":"36","author":"Busch","year":"1996","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0120","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1046\/j.1537-2995.1996.36396182141.x","article-title":"Relationship between antibody to Hepatitis B core antigen and retroviral infections in blood from volunteer donors","volume":"36","author":"Korelitz","year":"1996","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0125","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1182\/blood.V83.4.1143.1143","article-title":"Accuracy of supplementary serologic testing for human T-lymphotropic virus types I and II in US blood donors","volume":"83","author":"Busch","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0130","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/JCM.32.3.603-607.1994","article-title":"Evaluation of a p21e-spiked western blot (Immunoblot) in confirming human T-cell lymphotropic virus type I or II infection in volunteer blood donors","volume":"32","author":"Kleinman","year":"1994","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0135","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1046\/j.1537-2995.2000.40040443.x","article-title":"Absence of evidence of infection with divergent primate T-lymphotropic viruses in United States blood donors who have seroindeterminate HTLV test results","volume":"40","author":"Busch","year":"2000","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0140","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1046\/j.1537-2995.1995.351196110893.x","article-title":"Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection","volume":"35","author":"Busch","year":"1995","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0145","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1046\/j.1537-2995.2003.00521.x","article-title":"Impact of HCV 3.0 EIA relative to HCV 2.0 EIA on blood donor screening","volume":"43","author":"Tobler","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0150","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1046\/j.1537-2995.2000.40080917.x","article-title":"Performance of second- and third-generation RIBAs for confirmation of third-generation HCV EIA-reactive blood donations","volume":"40","author":"Tobler","year":"2000","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0155","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1046\/j.1537-2995.2001.41121625.x","article-title":"Misclassification of HCV viremic blood donors as indeterminate by RIBA 3.0 because of human superoxide dismutase (hSOD) reactivity (letter-to-the-editor)","volume":"41","author":"Tobler","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0160","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1046\/j.1537-2995.2003.00391.x","article-title":"Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening","volume":"43","author":"Kleinman","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0165","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/j.1537-2995.2004.04055.x","article-title":"Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and Anti-HBc: Implications for future HBV screening policy","volume":"44","author":"Kuhns","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0170","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1046\/j.1537-2995.2001.41091081.x","article-title":"HBV: Amplified and back in the blood safety spotlight","volume":"41","author":"Kleinman","year":"2001","journal-title":"Transfusion"},{"issue":"Suppl.","key":"10.1016\/j.tmrv.2012.04.004_bb0175","first-page":"92S","article-title":"Evaluation of HBsAg neutralization test positive donors with negative anti-HBc","volume":"38","author":"Kleinman","year":"1998","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0180","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1046\/j.1537-2995.2000.40050585.x","article-title":"False-negative testing errors in routine viral marker screening of blood donors","volume":"40","author":"Busch","year":"2000","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0185","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1537-2995.1997.37297203524.x","article-title":"Loss of volunteer blood donors because of unconfirmed enzyme immunoassay screening results","volume":"37","author":"Ownby","year":"1997","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0190","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1046\/j.1537-2995.2003.00291.x","article-title":"Impact of changes in viral marker screening assays","volume":"43","author":"Sharma","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0195","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/infdis\/jir862","article-title":"Genetic diversity of recently acquired and prevalent HIV, HBV and HCV infections 1 in US blood donors","volume":"205","author":"Delwart","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0200","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jama.289.8.959","article-title":"Current and emerging infectious risks of blood transfusion","volume":"289","author":"Busch","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0205","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00042560-199512050-00005","article-title":"Evaluation of four alternative methodologies for determination of absolute CD4+ lymphocyte counts","volume":"10","author":"Johnson","year":"1995","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1423-0410.2000.7810001.x","article-title":"Evaluation of the safety of Rh Immunoglobulin by monitoring viral markers among Rh negative female blood donors","volume":"78","author":"Watanabe","year":"2000","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0215","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.0041-1132.2005.04266.x","article-title":"Detection of West Nile virus RNA and antibody in frozen plasma components from a voluntary market withdrawal during the 2002 peak epidemic","volume":"45","author":"Tobler","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0220","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.0041-1132.2005.04315.x","article-title":"The 2003 West Nile virus United States epidemic: the America's Blood Centers experience","volume":"45","author":"Kleinman","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0225","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1086\/591467","article-title":"Virus and antibody dynamics in acute West Nile Virus infection","volume":"198","author":"Busch","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0230","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3201\/eid1203.051287","article-title":"West Nile Virus infections projected from blood donor screening data, United States, 2003","volume":"12","author":"Busch","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0235","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/j.1537-2995.2007.01264.x","article-title":"Influenza viremia and the potential for blood-borne transmission","volume":"47","author":"Likos","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0240","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/infdis\/jir863","article-title":"Sensitive detection assays for influenza RNA do not reveal viremia in US blood donors","volume":"205","author":"Stramer","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0245","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1537-2995.2011.03063.x","article-title":"The Blood Xenotropic Murine Leukemia Virus-Related Virus Scientific Working Group: mission, progress, and plans","volume":"51","author":"Simmons","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0250","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1126\/science.1213841","article-title":"Failure to confirm XMRV\/MLVs in the blood of patients with chronic fatigue syndrome: A multi-laboratory study","volume":"33","author":"Simmons","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0255","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1126\/science.1204963","article-title":"No evidence of murine-like gammaretroviruses in CFS patients previously identified as XMRV-infected","volume":"33","author":"Knox","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0260","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.1205292","article-title":"Recombinant origin of the retrovirus XMRV","volume":"33","author":"Paprotka","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0265","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1086\/598860","article-title":"Using blood donor and transfusion recipient biospecimen repositories to address emerging blood safety concerns and advance infectious disease research: The NHLBI Biologic Specimen Repository","volume":"199","author":"Busch","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0270","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/j.1537-2995.2005.00171.x","article-title":"The RADAR repository: A resource for studies of infectious agents and their transmissibility by transfusion","volume":"45","author":"Kleinman","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0275","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1111\/j.1537-2995.2010.02667.x","article-title":"Biospecimen repositories: Are blood donors willing to participate?","volume":"50","author":"Scott","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0280","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1046\/j.1537-2995.2001.41101249.x","article-title":"Multicenter evaluation of PCR methods for detecting CMV DNA in blood donors","volume":"41","author":"Roback","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0285","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1537-2995.2003.00312.x","article-title":"CMV DNA is rarely detected in healthy blood donors using validated PCR assays","volume":"43","author":"Roback","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0290","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1046\/j.1537-2995.2003.00490.x","article-title":"Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence in US blood donors","volume":"43","author":"Pellett","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0295","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1111\/j.1537-2995.2007.01341.x","article-title":"Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay","volume":"47","author":"Kleinman","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0300","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1182\/blood-2009-06-225706","article-title":"A linked donor-recipient study to evaluate parvovirus B19 transmission by blood component transfusion","volume":"114","author":"Kleinman","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0305","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1111\/j.1537-2995.2010.03035.x","article-title":"Distribution of B19 virus DNA in blood compartments and persistence of virus in blood donors","volume":"51","author":"Lee","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0310","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1001\/jama.1996.03530370033027","article-title":"Demographic determinants of hepatitis C virus seroprevalence among blood donors","volume":"275","author":"Murphy","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0315","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/hep.510310329","article-title":"Risk factors for hepatitis C virus infection in United States blood donors","volume":"31","author":"Murphy","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0320","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1537-2995.2006.00745.x","article-title":"Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors","volume":"46","author":"Busch","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0325","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0330","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1086\/654882","article-title":"Hepatitis C virus prevalence and clearance among U.S. blood donors, 2006-2007: Associations with birth cohort, multiple pregnancies and body mass index","volume":"202","author":"Murphy","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0335","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00042560-199703010-00011","article-title":"Risk factors for human T-cell lymphotropic virus types I and II (HTLV-I and -II) in blood donors: the Retrovirus Epidemiology Donor Study","volume":"14","author":"Schreiber","year":"1997","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0340","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1086\/315139","article-title":"Evidence among blood donors for a 30-year-old epidemic of human T lymphotropic virus type II infection in the United States","volume":"180","author":"Murphy","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0345","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.1997.03540360035027","article-title":"Estimates of infectious disease risk factors in US blood donors","volume":"277","author":"Williams","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0350","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1046\/j.1537-2995.1998.38498257373.x","article-title":"Demographic characteristics, unreported risk behaviors, and the prevalence and incidence of viral infections: A comparison of apheresis and whole-blood donors","volume":"38","author":"Glynn","year":"1998","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0355","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1046\/j.1537-2995.2003.00532.x","article-title":"Behavioral and infectious disease risks in young blood donors: Implications for recruitment","volume":"43","author":"Damesyn","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1537-2995.2005.03421.x","article-title":"The impact of male-to-male sexual experience on risk profiles of blood donors","volume":"45","author":"Sanchez","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0365","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1046\/j.1537-2995.2001.41020172.x","article-title":"The potential impact of incentives on future blood donation behavior","volume":"41","author":"Sanchez","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0370","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1046\/j.1537-2995.2001.41060736.x","article-title":"Repeat whole-blood and plateletpheresis donors: unreported deferrable risks, reactive screening tests, and response to incentive programs","volume":"41","author":"Glynn","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0375","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1001\/jama.286.12.1475","article-title":"Prevalence, donation practices, and risk assessment of blood donors with hemochromatosis","volume":"286","author":"Sanchez","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0380","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1537-2995.2004.03347.x","article-title":"The donor notification process from the donor's perspective","volume":"44","author":"Kleinman","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0385","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1046\/j.1537-2995.1998.38111299056317.x","article-title":"Psychological distress in blood donors notified of HTLV-I\/II infection","volume":"38","author":"Guiltinan","year":"1998","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0390","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1046\/j.1537-2995.2003.00473.x","article-title":"Do blood donors read and understand screening educational materials?","volume":"43","author":"Ruguge Hakiza","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0395","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1046\/j.1537-2995.2001.41111341.x","article-title":"Knowledge of HIV\/AIDS transmission and screening in United States blood donors","volume":"41","author":"Sharma","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0400","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1537-2995.2003.00295.x","article-title":"Blood donor perceptions of health history screening with a computer-assisted self-administered interview","volume":"43","author":"Sanchez","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0405","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1046\/j.1537-2995.1994.341095026972.x","article-title":"Demographic characteristics and prevalence of serologic markers among donors who use the confidential unit exclusion process: the Retrovirus Epidemiology Donor Study","volume":"34","author":"Korelitz","year":"1994","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0410","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1537-2995.1996.36396182135.x","article-title":"Antigen testing for human immunodeficiency virus (HIV) and the magnet effect: will the benefit of a new HIV test be offset by the numbers of higher-risk, test-seeking donors attracted to blood centers?","volume":"36","author":"Korelitz","year":"1996","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0415","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/j.1537-2995.2004.04034.x","article-title":"Comparison of demographic and donation profiles and transfusion-transmissible disease markers and risk rates in previously transmitted and non-transfused blood donors","volume":"44","author":"Wang","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0420","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1046\/j.1537-2995.1997.371098016436.x","article-title":"Potential increased risk of virus transmission due to exclusion of older donors because of concern over Creutzfeldt-Jakob disease","volume":"37","author":"Busch","year":"1997","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0425","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1537-2995.2004.03114.x","article-title":"Mammalian brain consumption by blood donors in the United States: Brains today, deferred tomorrow?","volume":"44","author":"Schreiber","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0430","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1111\/j.1537-2995.2009.02290.x","article-title":"Risk for malaria in United States donors deferred for travel to malaria-endemic areas","volume":"49","author":"Spencer","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0435","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1111\/j.1537-2995.2011.03158.x","article-title":"Deconstructing the risk for malaria in United States donors deferred for travel to Mexico","volume":"51","author":"Spencer","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0440","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0140-6736(93)90529-P","article-title":"HTLV-II associated myelopathy in 43-year-old woman","volume":"341","author":"Murphy","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0445","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1212\/WNL.48.2.315","article-title":"HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II infected blood donors","volume":"48","author":"Murphy","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0450","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1212\/01.WNL.0000096011.92542.DA","article-title":"Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study","volume":"61","author":"Orland","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0455","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1086\/514143","article-title":"Increased prevalence of infectious diseases and other adverse outcomes in human T lymphotropic virus types I- and II-infected blood donors","volume":"176","author":"Murphy","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0460","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1001\/archinte.159.13.1485","article-title":"Increased incidence of infectious diseases during prospective follow-up of human T-lymphotropic virus type II- and -I infected blood donors","volume":"159","author":"Murphy","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0465","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3201\/eid1001.020714","article-title":"Respiratory and urinary tract infections, arthritis, and asthma associated with HTLV-I and HTLV-II infection","volume":"10","author":"Murphy","year":"2004","journal-title":"Emerg Inf Dis"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2466-3-1","article-title":"Pulmonary function testing in HTLV-I and HTLV-II infected humans: A cohort study","volume":"3","author":"Murphy","year":"2003","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0475","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1089\/088922201750461339","article-title":"Delayed hypersensitivity skin testing to mumps and Candida albicans antigens is normal in middle-aged HTLV-I and -II infected U.S. cohorts","volume":"17","author":"Murphy","year":"2001","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0480","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1086\/428505","article-title":"Human T lymphotropic virus type II infection and humoral responses to pneumococcal polysaccharide and tetanus toxoid vaccines","volume":"19","author":"Jarvis","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0485","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jcv.2004.05.016","article-title":"Quantitation of HTLV-I and II proviral load using real-time quantitative PCR with SYBR Green chemistry","volume":"31","author":"Lee","year":"2004","journal-title":"J Clin Virol"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0490","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1086\/422398","article-title":"Higher human T lymphotropic virus (HTLV) provirus load is associated with HTLV-I versus HTLV-II, with HTLV-II subtype A versus B, and with male sex and a history of blood transfusion","volume":"190","author":"Murphy","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0495","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1086\/508899","article-title":"Long-term variations in human T lymphotropic virus (HTLV)-I and HTLV-II proviral loads and association with clinical data","volume":"194","author":"Kwaan","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0500","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00042560-199606010-00014","article-title":"Male-to-female transmission of human T-cell lymphotropic virus types I and II: association with viral load","volume":"12","author":"Kaplan","year":"1996","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0505","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1086\/429410","article-title":"A prospective study of sexual transmission of human T lymphotropic virus (HTLV)-I and HTLV-II","volume":"191","author":"Roucoux","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0510","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1182\/blood-2008-05-155960","article-title":"Long-term increases in lymphocytes and platelets in human T-lymphotropic virus type II infection","volume":"112","author":"Bartman","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0515","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/00042560-199804010-00007","article-title":"Laboratory test differences associated with HTLV-I and HTLV-II infection","volume":"17","author":"Murphy","year":"1998","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0520","doi-asserted-by":"crossref","first-page":"550","DOI":"10.5858\/2000-124-0550-LAIFBD","article-title":"Laboratory abnormalities in former blood donors seropositive for human T-lymphotropic virus types 1 and 2: A prospective analysis","volume":"124","author":"Glynn","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0525","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1182\/blood-2008-09-179879","article-title":"Human T-cell leukemia virus type 2 produces a spliced antisense transcript encoding a protein that lacks a classic bZIP domain but still inhibits Tax2-mediated transcription","volume":"114","author":"Halin","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0530","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1006\/viro.1997.9009","article-title":"Molecular epidemiology of HTLV-II among United States blood donors and intravenous drug users: An age cohort effect for HTLV-II RFLP subtype AO","volume":"242","author":"Murphy","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0535","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1006\/viro.2000.0632","article-title":"Human T-lymphotropic virus type II RFLP subtypes a0 and b4\/b5 are associated with different demographic and geographic characteristics in the United States","volume":"279","author":"Liu","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0540","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1046\/j.1537-2995.2001.41030360.x","article-title":"First-time blood donors: Demographic trends","volume":"41","author":"Wu","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0545","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1111\/j.1537-2995.2009.02271.x","article-title":"Minority and foreign-born representation among US blood donors: Demographics and donation frequency for 2006","volume":"49","author":"Murphy","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0550","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1046\/j.1525-1438.2002.00084.x","article-title":"HIV seroconverting donors delay their return: screening test implications","volume":"42","author":"Schreiber","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0555","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/biostatistics\/5.1.145","article-title":"How special is a \u201cspecial\u201d interval: Modeling departure from length-based sampling in renewal processes","volume":"5","author":"Satten","year":"2004","journal-title":"Biostatistics"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0560","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1001\/jama.289.17.2246","article-title":"Effect of a national disaster on blood supply and safety: The September 11 experience","volume":"289","author":"Glynn","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0565","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1046\/j.1537-2995.1999.39101128.x","article-title":"Analysis of donor return behavior","volume":"39","author":"Ownby","year":"1999","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0570","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1537-2995.2003.00290.x","article-title":"Lapsed donors: An untapped resource","volume":"43","author":"Schreiber","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0575","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1046\/j.1537-2995.2003.00388.x","article-title":"Increasing blood availability by changing donation patterns","volume":"43","author":"Schreiber","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0580","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1423-0410.2005.00593.x","article-title":"First year donation patterns predict long term commitment for first-time donors","volume":"88","author":"Schreiber","year":"2005","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0585","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1537-2995.2011.03235.x","article-title":"Donation return time at fixed and mobile donation sites","volume":"52","author":"Carey","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0590","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1537-2995.2006.00757.x","article-title":"Convenience, the bane of our existence, and other barriers to donating","volume":"46","author":"Schreiber","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0595","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1537-2995.2007.01519.x","article-title":"Factors influencing donor return","volume":"48","author":"Schlumpf","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0600","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/j.1537-2995.2006.00831.x","article-title":"Factors influencing the decision to donate: Racial and ethnic comparisons","volume":"46","author":"Glynn","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0605","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1537-2995.2007.01481.x","article-title":"The role of altruistic behavior, empathetic concern and social responsibility motivation in blood donation behavior","volume":"48","author":"Steele","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0610","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1046\/j.1537-2995.1998.38498257374.x","article-title":"Retention of \u201csafe\u201d blood donors","volume":"38","author":"Thomson","year":"1998","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0615","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1046\/j.1537-2995.2002.00008.x","article-title":"Motivations to donate blood: Demographic comparisons","volume":"42","author":"Glynn","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0620","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1537-2995.2003.00252.x","article-title":"Attitudes towards blood donation incentives in the United States: Implications for donor recruitment","volume":"43","author":"Glynn","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0625","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1537-2995.2004.03338.x","article-title":"ABO and Rh (D) phenotype frequencies of different racial\/ethnic groups in the United States","volume":"44","author":"Garratty","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0630","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1111\/j.1537-2995.2010.02649.x","article-title":"Demographic risk factors for low hematocrit deferral in whole blood donors","volume":"50","author":"Mast","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0635","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1537-2995.2010.02989.x","article-title":"Donor return after temporary deferral","volume":"51","author":"Custer","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0640","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1537-2995.2011.03353.x","article-title":"Demographics of successful, unsuccessful and deferral visits at six blood centers over a 4-year period","volume":"52","author":"Custer","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0645","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1537-2995.2011.03216.x","article-title":"Adverse reactions and other factors that impact subsequent blood donation visits","volume":"52","author":"Custer","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0650","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/j.1537-2995.2009.02578.x","article-title":"The potential impact of selective donor deferrals based on estimated blood volume on vasovagal reactions and donor deferral rates","volume":"50","author":"Rios","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0655","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/j.1537-2995.2010.03043.x","article-title":"Characteristics of post-donation information donors and comparison with appropriately deferred donors","volume":"51","author":"Wilkinson","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0660","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1537-2995.2011.03430.x","article-title":"Donors' perspectives on their postdonation information (PDI) event: a qualitative interview study of PDI donors","volume":"52","author":"Wilkinson","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0665","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1537-2995.2010.02865.x","article-title":"Iron deficiency in blood donors: Analysis of enrollment data from the REDS-II Donor Iron Status Evaluation (RISE) Study","volume":"51","author":"Cable","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0670","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1537-2995.2011.03401.x","article-title":"Iron deficiency in blood donors: The REDS-II donor iron status evaluation (RISE) study","volume":"52","author":"Cable","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0675","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/j.1537-2995.2010.03002.x","article-title":"Donation frequency of blood donors participating in a prospective cohort study of iron status","volume":"51","author":"Bahrami","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0680","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1365-2141.2011.08952.x","article-title":"The impact of HFE mutations on hemoglobin and iron status in individuals undergoing repeated iron loss through blood donation","volume":"156","author":"Mast","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0685","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/j.1537-2995.2011.03389.x","article-title":"The difference between fingerstick and venous hemoglobin\/hematocrit varies by gender and iron stores","volume":"52","author":"Cable","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0690","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1537-2995.2007.01184.x","article-title":"Donor risk factors for white blood cell antibodies associated with transfusion-associated acute lung injury: REDS-II Leukocyte Antibody Prevalence Study (LAPS). (editorial)","volume":"47","author":"Triulzi","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0695","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1111\/j.1537-2995.2009.02206.x","article-title":"The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors and implications for a Transfusion Related Acute Lung Injury (TRALI) risk reduction strategy","volume":"49","author":"Triulzi","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0700","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1537-2995.2008.01955.x","article-title":"Long-term in vitro reactivity for HLA antibodies and comparison of detection using serum vs. plasma","volume":"49","author":"Norris","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0705","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1111\/j.1537-2995.2010.02589.x","article-title":"Specificities of HLA Antibodies in blood donors: Baseline data for a TRALI lookback study","volume":"50","author":"Endres","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0710","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/j.1537-2995.2009.02556.x","article-title":"Prevalence of HLA antibodies in remotely transfused or alloexposed volunteer blood donors","volume":"50","author":"Kakaiya","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0715","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/j.1537-2995.2010.02991.x","article-title":"Blood donations from previously transfused or pregnant donors: A multi-center study to determine the frequency of allo-exposure","volume":"51","author":"Rios","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0720","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1111\/j.1537-2995.2010.03048.x","article-title":"Establishing assay cutoffs for HLA Antibody screening of apheresis donors","volume":"51","author":"Carrick","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0725","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1537-2995.2010.02938.x","article-title":"Agreement amongst HLA antibody detection assays is higher in ever pregnant donors and improved using a consensus cutoff","volume":"51","author":"Carrick","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0730","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1537-2995.2010.02913.x","article-title":"The frequency and specificity of human neutrophil antigen antibodies in a blood donor population","volume":"51","author":"Gottschall","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0735","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1111\/j.1537-2995.2011.03120.x","article-title":"The Leukocyte Antibody Prevalence Study-II (LAPS-II): A retrospective cohort comparison study of transfusion related acute lung injury (TRALI) in recipients of high plasma volume HLA antibody positive or negative components","volume":"51","author":"Kleinman","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0740","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1537-2995.2009.02529.x","article-title":"Demographic profile of blood donors at three major Brazilian blood centers: Results from the international REDS-II study, 2007 to 2008","volume":"50","author":"Carneiro-Proietti","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0745","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1537-2995.2010.02799.x","article-title":"Demographic characteristics and prevalence of serologic markers among blood donors who use confidential unit exclusion (CUE) in S\u00e3o Paulo, Brazil: Implications for modification of CUE polices in Brazil","volume":"51","author":"Almeida-Neto","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0750","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1111\/j.1537-2995.2010.02756.x","article-title":"Enhanced classification of Chagas serologic results and epidemiologic characteristics of seropositive donors at three large blood centers in Brazil","volume":"50","author":"Sabino","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0755","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1537-2995.2010.02773.x","article-title":"Performance of parallel screening of Brazilian blood donors with two HIV immunoassays: Implications for sequential immunoassay testing algorithms in other countries","volume":"51","author":"Sabino","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0760","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/j.1537-2995.2011.03344.x","article-title":"HIV prevalence, incidence and residual risk of transmission by transfusions at REDS-II blood centers in Brazil","volume":"52","author":"Sabino","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0765","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1537-2995.2011.03248.x","article-title":"Number of recent sexual partners among blood donors in Brazil: Associations with donor demographics, donation characteristics and infectious disease markers","volume":"52","author":"Patavino","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0770","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.1537-2995.2009.02526.x","article-title":"The impact of simple donor education on donor behavioral deferral and infectious disease rates in S\u00e3o Paulo, Brazil","volume":"50","author":"Goncalez","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0775","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1111\/j.1537-2995.2010.02650.x","article-title":"Human immunodeficiency virus test-seeking blood donors in a large blood bank in S\u00e3o Paulo, Brazil","volume":"50","author":"Goncalez","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0780","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1537-2995.2011.03387.x","article-title":"Blood transfusion utilization and recipient survival at Hospital das Clinicas in S\u00e3o Paulo, Brazil","volume":"52","author":"Goncalez","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0785","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1111\/j.1537-2995.2010.02722.x","article-title":"Who donates blood at 5 ethnically and geographically diverse blood centers in China in 2008","volume":"50","author":"Wang","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0790","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1111\/j.1537-2995.2010.02665.x","article-title":"Impact of the May 12, 2008, earthquake on blood donations across five Chinese blood centers","volume":"50","author":"Liu","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0795","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1423-0410.2011.01557.x","article-title":"First time donors responding to a national disaster may be an untapped resource for the blood center","volume":"102","author":"Guo","year":"2012","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0800","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1537-2995.2010.02876.x","article-title":"International Component. Analysis of Chinese donors' return behavior","volume":"51","author":"Guo","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0805","doi-asserted-by":"crossref","DOI":"10.1111\/j.1537-2995.2011.03527.x","article-title":"The increasing prevalence of serologic markers for syphilis among Chinese blood donors in 2008-2010 during a syphilis epidemic","author":"Liu","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0810","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1111\/j.1537-2995.2011.03215.x","article-title":"Hepatitis B virus nucleic acid testing in Chinese blood donors with normal and elevated alanine aminotransferase","volume":"51","author":"Ren","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2012.04.004_bb0815","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1537-2995.2011.03415.x","article-title":"International Component. The Human Immunodeficiency Virus-1 genotype diversity and drug resistance mutations profile of blood donors from five Chinese blood centers","volume":"52","author":"Zeng","year":"2012","journal-title":"Transfusion"}],"container-title":["Transfusion Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796312000259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796312000259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T15:40:32Z","timestamp":1713973232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887796312000259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":163,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0887796312000259"],"URL":"https:\/\/doi.org\/10.1016\/j.tmrv.2012.04.004","relation":{},"ISSN":["0887-7963"],"issn-type":[{"value":"0887-7963","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}